Document Detail

Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.
MedLine Citation:
PMID:  18199844     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVES: Natriuretic peptides have been suggested to be of value in risk stratification in dialysis patients. Data in patients on peritoneal dialysis remain limited.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients of the ADEMEX trial (ADEquacy of peritoneal dialysis in MEXico) were randomized to a control group [standard 4 x 2L continuous ambulatory peritoneal dialysis (CAPD); n = 484] and an intervention group (CAPD with a target creatinine clearance > or =60 L/wk/1.73 m(2); n = 481). Natriuretic peptides were measured at baseline and correlated with other parameters as well as evaluated for effects on patient outcomes.
RESULTS: Control group and intervention group were comparable at baseline with respect to all measured parameters. Baseline values of natriuretic peptides were elevated and correlated significantly with levels of residual renal function but not with body size or diabetes. Baseline values of N-terminal fragment of B-type natriuretic peptide (NT-proBNP) but not proANP(1-30), proANP(31-67), or proANP(1-98) were independently highly predictive of overall survival and cardiovascular mortality. Volume removal was also significantly correlated with patient survival.
CONCLUSIONS: NT-proBNP have a significant predictive value for survival of CAPD patients and may be of value in guiding risk stratification and potentially targeted therapeutic interventions.
Ramon Paniagua; Dante Amato; Salim Mujais; Edward Vonesh; Alfonso Ramos; Ricardo Correa-Rotter; Walter H Horl
Related Documents :
9509564 - Renal involvement in the systemic inflammatory reaction syndrome.
17986544 - How to have--a successful peritoneal dialysis program.
19808224 - Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis...
2613484 - Assessment of liver ability to biotransformation of antipyrine in uraemic patients on r...
23669024 - Diagnostic yield of egd in children: a retrospective single-center study of 1000 cases.
11077774 - Superior mesenteric artery bypass for chronic mesenteric ischaemia: a dgh experience.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-01-16
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  3     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-29     Completed Date:  2008-06-23     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  407-15     Citation Subset:  IM    
Mexican Nephrology Collaborative Study Group, Unidad de Investigacioñ Médica en Enfermedades Nefrolìicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Kidney Failure, Chronic / blood*,  mortality,  therapy*
Natriuretic Peptide, Brain / blood*
Peritoneal Dialysis, Continuous Ambulatory*
Predictive Value of Tests
Prospective Studies
Risk Assessment
Survival Rate
Reg. No./Substance:
114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of d...
Next Document:  Weekly averaged blood pressure is more important than a single-point blood pressure measurement in t...